Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 16 studies | 31% ± 13% | |
| peripheral blood | 15 studies | 31% ± 9% | |
| kidney | 8 studies | 30% ± 11% | |
| brain | 8 studies | 30% ± 11% | |
| intestine | 7 studies | 33% ± 13% | |
| eye | 7 studies | 26% ± 9% | |
| bone marrow | 5 studies | 25% ± 6% | |
| liver | 5 studies | 36% ± 20% | |
| lymph node | 5 studies | 35% ± 6% | |
| pancreas | 4 studies | 43% ± 17% | |
| uterus | 4 studies | 38% ± 13% | |
| breast | 4 studies | 31% ± 2% | |
| placenta | 3 studies | 37% ± 10% | |
| adrenal gland | 3 studies | 28% ± 8% | |
| prostate | 3 studies | 35% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6751.58 | 1445 / 1445 | 100% | 168.98 | 183 / 183 |
| ovary | 100% | 9509.84 | 180 / 180 | 100% | 171.54 | 430 / 430 |
| stomach | 100% | 5603.68 | 359 / 359 | 100% | 164.95 | 286 / 286 |
| pancreas | 100% | 5770.20 | 327 / 328 | 100% | 112.43 | 178 / 178 |
| breast | 100% | 7138.91 | 459 / 459 | 100% | 184.15 | 1114 / 1118 |
| intestine | 100% | 6379.05 | 966 / 966 | 100% | 188.09 | 525 / 527 |
| lung | 100% | 5710.43 | 576 / 578 | 100% | 190.90 | 1154 / 1155 |
| uterus | 100% | 7773.78 | 170 / 170 | 100% | 188.12 | 457 / 459 |
| thymus | 100% | 5602.39 | 653 / 653 | 99% | 136.83 | 600 / 605 |
| bladder | 100% | 7185.76 | 21 / 21 | 99% | 183.76 | 499 / 504 |
| brain | 99% | 4919.52 | 2617 / 2642 | 100% | 141.14 | 704 / 705 |
| prostate | 100% | 5277.55 | 245 / 245 | 99% | 142.19 | 496 / 502 |
| skin | 100% | 9196.12 | 1809 / 1809 | 99% | 170.97 | 466 / 472 |
| kidney | 100% | 5192.72 | 89 / 89 | 97% | 107.09 | 870 / 901 |
| liver | 99% | 3161.42 | 224 / 226 | 97% | 89.16 | 395 / 406 |
| adrenal gland | 100% | 7206.72 | 258 / 258 | 90% | 106.69 | 208 / 230 |
| adipose | 100% | 7062.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 266.95 | 29 / 29 |
| muscle | 100% | 6307.31 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5938.85 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 172.96 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 48.56 | 1 / 1 |
| blood vessel | 100% | 6404.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 149.23 | 78 / 80 |
| heart | 96% | 4703.89 | 828 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 89% | 5540.20 | 828 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007339 | Biological process | binding of sperm to zona pellucida |
| GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
| GO_0061077 | Biological process | chaperone-mediated protein folding |
| GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
| GO_1904851 | Biological process | positive regulation of establishment of protein localization to telomere |
| GO_0006457 | Biological process | protein folding |
| GO_0050821 | Biological process | protein stabilization |
| GO_0090666 | Biological process | scaRNA localization to Cajal body |
| GO_0051973 | Biological process | positive regulation of telomerase activity |
| GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
| GO_0005874 | Cellular component | microtubule |
| GO_0005832 | Cellular component | chaperonin-containing T-complex |
| GO_0002199 | Cellular component | zona pellucida receptor complex |
| GO_0005813 | Cellular component | centrosome |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0042995 | Cellular component | cell projection |
| GO_0044297 | Cellular component | cell body |
| GO_0042470 | Cellular component | melanosome |
| GO_0044183 | Molecular function | protein folding chaperone |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
| GO_0005524 | Molecular function | ATP binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| Gene name | CCT4 |
| Protein name | T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding) |
| Synonyms | SRB CCTD |
| Description | FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis . The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance . As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia . The TRiC complex plays a role in the folding of actin and tubulin (Probable). . |
| Accessions | ENST00000544079.2 [P50991-2] ENST00000394440.8 [P50991-1] P50991 |